Photo of Scott Franklin
R United States House · District 18 · Florida On the 2026 ballot

Rep. Scott Franklin

Compare
Total votes
2,818
all sessions
Attendance
99%
30 missed
Higher than 80% of chamber peers
With party
96%
of cast votes
Higher than 89% of chamber peers
Bipartisan score
2%
crosses aisle rarely
Lower than 89% of chamber peers
Sponsored
868
bills & resolutions
Near the chamber average
Committees
6
assignments
868 bills and resolutions

Sponsored bills

Total
868
Primary
47
Co-sponsor
821
This page
868
matching current filters
Co-sponsor HR 1262
Passed · Washington House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HR 6130
In committee · Washington House · Co-sponsor
ASAP Act

Maddy summaryThis bill would require Medicare to cover early detection screening tests for Alzheimer's disease and related dementias starting January 1, 2028. It defines eligible tests as FDA-cleared genomic blood tests, blood product analyses, or equivalent medical imaging methods (like protein expression or whole genome sequencing) that detect pre-symptomatic or early-stage conditions. Medicare beneficiaries would receive this coverage without cost-sharing for these specific screenings. The bill amends Medicare coverage rules to explicitly include these tests under Section 1861(nnn) of the Social Security Act.

In committee Nov 19, 2025 1 co-sponsor
Co-sponsor HR 1109
In committee · Washington House · Co-sponsor
Litigation Transparency Act of 2025

Maddy summaryHR 1109, the Litigation Transparency Act of 2025, requires parties and their lawyers in civil lawsuits to disclose to the court and other parties the identity of any person or group that could receive payment if the case succeeds (like investors or lenders), and to provide copies of related agreements. Exceptions apply for simple loan repayments (with interest limits) or attorney fee reimbursements. Disclosures must be made within 10 days of signing such agreements or when filing the case, and must be updated if inaccurate. This applies to all civil cases filed after the law takes effect, aiming to increase transparency in litigation funding arrangements.

In committee Nov 19, 2025 1 co-sponsor
Co-sponsor HR 6068
In committee · Washington House · Co-sponsor
PROTECT Florida Act

Maddy summaryHR 6068, the PROTECT Florida Act, extends the existing moratorium on oil and gas leasing and exploration in the Gulf of Mexico through 2032 and adds a new, permanent ban on these activities off Florida’s Atlantic coast. It directly affects federal agencies (like the Department of the Interior), which cannot issue permits for oil/gas exploration, seismic testing, or related activities in two specific zones: the Straits of Florida and the South Atlantic Planning Area south of Florida’s coastline. The bill blocks all leasing, preleasing, and exploration permits in these areas from enactment until June 30, 2032. This policy change prevents new offshore drilling and seismic surveys in Florida’s coastal waters, aiming to protect marine environments and coastal communities.

In committee Nov 17, 2025 1 co-sponsor
Co-sponsor HR 979
In committee · Washington House · Co-sponsor
AM Radio for Every Vehicle Act of 2025

Maddy summaryThis bill requires all new passenger vehicles manufactured for sale in the U.S. to include AM radio as standard equipment (not an optional add-on) by 2027-2028, depending on manufacturer size. It mandates that AM radio receivers must be easily accessible to drivers and allows compliance through digital AM broadcast technology. During a transition period, manufacturers must clearly label vehicles without AM radio but cannot charge extra for this feature. The bill also mandates a GAO study on AM radio's role in emergency alerts and includes a 10-year sunset provision for the rule. It preempts state laws regarding AM radio access in vehicles.

In committee Nov 12, 2025 1 co-sponsor
Primary HR 5908
In committee · Washington House · Lead sponsor
Non-Essential Workers Transparency Act

Maddy summaryThis bill requires U.S. Executive agencies to report detailed workforce data when a government funding lapse (covered period) ends. Agencies must submit within 30 days a report showing the total number of employees before the lapse, salaries paid during the prior fiscal year, and specific counts/pay rates for both furloughed (non-essential) workers and others during the lapse. The reports, submitted to designated congressional committees, will be published online for public access. Additionally, the Congressional Budget Office must issue a public report on the economic impact of each funding lapse. The bill affects all Executive agencies (like federal departments) and mandates transparency about workforce impacts during government shutdowns.

In committee Nov 4, 2025 0 co-sponsors
Co-sponsor HR 842
In committee · Washington House · Co-sponsor
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Maddy summaryThis bill adds Medicare coverage for multi-cancer early detection screening tests (blood or biological tests analyzing cell-free DNA) starting January 1, 2028. It directly affects Medicare beneficiaries aged 68 and older (starting in 2028, with the age limit increasing by 1 year annually), requiring tests to be FDA-cleared and deemed reasonable/necessary by the Secretary for early cancer detection across multiple organ sites. Payment will initially match current stool DNA test rates before 2031, then shift to a lower rate or new payment system after 2031, with limits preventing more than one test per year. The bill explicitly states it does not alter coverage for existing cancer screenings like breast, colorectal, or prostate cancer tests.

In committee Oct 3, 2025 1 co-sponsor
Co-sponsor HR 38
In committee · Washington House · Co-sponsor
Constitutional Concealed Carry Reciprocity Act of 2025

Maddy summaryThis bill would require all states to recognize valid concealed carry permits issued by other states, allowing permit holders to carry concealed handguns (excluding machine guns) in any state that either issues such permits or doesn't prohibit concealed carry. It directly affects law-abiding gun owners with valid permits from their home state, ensuring they can carry in states with similar permit systems or no prohibitions. Key provisions include treating valid permit documents as proof of legal carry (reducing officer stops), shifting the burden of proof to prosecutors if challenged, and allowing civil lawsuits for violations with attorney's fee awards. The bill does not override state laws restricting firearms on private property or government land, nor does it affect federal gun restrictions like those in section 922(q).

In committee Oct 3, 2025 1 co-sponsor
Co-sponsor HR 5626
In committee · Washington House · Co-sponsor
Taiwan and American Space Assistance Act of 2025

Maddy summaryThis bill requires NASA and NOAA to establish civilian space cooperation with Taiwan within 90 days of enactment, focusing on satellite programs, weather technology, and personnel exchanges. It mandates that these efforts comply with the Taiwan Relations Act and U.S. export rules while protecting U.S. intellectual property and economic interests. The agencies must submit annual reports to Congress detailing cooperation activities, challenges, and progress for five years after enactment. The bill directly affects U.S. space agencies and Taiwan’s space agency, facilitating non-military space collaboration. It does not alter existing U.S. policy toward Taiwan but creates a formal mechanism for expanded technical engagement.

In committee Sep 30, 2025 1 co-sponsor
Co-sponsor HRES 719
Passed · Washington House · Co-sponsor
Honoring the life and legacy of Charles Charlie James Kirk.

Maddy summaryHRES 719 is a House resolution honoring Charles "Charlie" James Kirk, the founder of Turning Point USA who was assassinated on September 10, 2025. The resolution condemns his assassination and all political violence, extends condolences to his family, and calls on Americans to reject violence while promoting civil discourse. It specifically recognizes Kirk's legacy as a defender of constitutional principles and his role in inspiring youth through free speech and faith-based civic engagement. As a commemorative resolution, it does not enact policy changes but formally expresses the House's stance on honoring his life and legacy.

Passed Sep 19, 2025 1 co-sponsor
Showing 61 to 70 of 868 bills
Previous 1 6 7 8 87 Next